WEDNESDAY, MARCH 18

11:00am – 3:30pm: INSTITUTES
1:00 – 4:00pm: HIV PCP INSTITUTE
1:00 – 5:00pm: HIV PNC INSTITUTE
4:00 – 5:30pm: TRACK SESSIONS

THURSDAY, MARCH 19

9:00 – 10:30am: PLENARY SESSION
10:45am – 12:15pm: TRACK SESSIONS
12:30 – 2:00pm: LUNCH PLENARY
2:15 – 3:45pm: TRACK SESSIONS
4:00 – 5:30pm: TRACK SESSIONS

FRIDAY, MARCH 20

9:00 – 10:30am: PLENARY SESSION
10:45am – 12:15pm: TRACK SESSIONS
12:30 – 2:00pm: LUNCH PLENARY

This schedule is preliminary and subject to change.

Aging Adolescents and Young Adults with HIV: Navigating the Second Transition in HIV Care

HIV Care and Treatment Track
Studio B

Having previously reported on clinical outcomes of Adolescents and Young Adults with HIV (AYAHIV) in the Accessing Care Early (ACE) young adult transition program, we present an update, detailing the design and implementation of this multi-dimensional program, the innovations in biomedical and care delivery interventions, as well as programmatic challenges and opportunities as we evolve into a mature transition program. This workshop will use didactics and interactive presentation, case-study, transparent panel discussion and Q&A as participants engage with the ACE program’s multidisciplinary team, including an YAHIV who “came of age” in the program.

HIV and Cognitive Decline: Understanding HIV-Associated Neurocognitive Disorder

HIV Care and Treatment Track
Studio F

With advancements in HIV treatment, individuals living with HIV are now living longer, By 2030, 70% of people living with HIV (PLWH) will be ages 50 and older. But, as PLWH age they face unique challenges, particularly with cognitive health. One major concern is HIV-Associated Neurocognitive Disorder (HAND), a form of cognitive decline more common among PLWH. This presentation will provide a brief overview of HIV care; the signs and risk factors for HAND; similarities and differences between HAND and Alzheimer's disease; and why accurately diagnosing cognitive change in PLWH is so important.

Navigating HIV in Pregnancy: Clinical Scenarios and Guideline-Based Management for Infants and Pregnant People

HIV Care and Treatment Track
Studio F

This presentation will explore critical considerations in the management of HIV in the context of pregnancy, focusing on evidence-based practices and clinical guidelines. Divided into three clinically relevant scenarios, the session will address: (1) treatment and monitoring of HIV in pregnant individuals, (2) postnatal management of infants with in utero exposure to HIV, and (3) considerations for HIV-positive parents who plan to breastfeed. Each topic will be anchored by a clinical case, offering participants an opportunity to apply current guidelines. Emphasis will be placed on reducing risk of perinatal HIV transmission, optimizing maternal and infant outcomes, and navigating ethical and cultural factors in decision making. Attendees will leave with practical clinical pearls and an updated understanding of best practices in HIV care during pregnancy and the postpartum period.

Hartford Employment Initiative: Addressing Critical Employment Gaps for Persons Living with HIV (PLWH)

HIV Care and Treatment Track
Studio C

The employment landscape for PLWH in the Hartford Transitional Grant Area (TGA) presents significant challenges. According to the 2022 Statewide Needs Assessment Survey, 54.46% of PLWH were unemployed, with 59.46% unemployment within the TGA. Among respondents, 78% of individuals over 50 lacked access to career and life skills training, limiting their ability to secure stable, fulfilling employment.

Aging While Black and LGBTQ+/SGL: Legacy, Equity, and the HIV Long-Term Survivor Experience

HIV Care and Treatment Track
Studio B

This interactive session explores the intersection of aging, race, gender identity, and sexuality through the lens of Black LGBTQ+/SGL individuals living with HIV. Drawing from lived experiences and frameworks like Aging While Black by Raymond Jetson, the session redefines aging not as decline, but as a site for power, healing, and systemic transformation.

Unlocking the Potential of Long-Acting Injectable Therapies for HIV Prevention and Treatment

Studio A

In this transformative session, we will delve into the powerful potential of long-acting injectable (LAI) strategies to not only prevent and treat HIV but to foster deeper, more meaningful healthcare engagement. With a focus on the tangible and intangible benefits of LAI therapy, this session will equip healthcare providers with practical insights and tools to optimize patient care and health outcomes. Participants will explore the multidimensional benefits of LAI therapy, highlighting how regular clinic visits can strengthen patient-provider relationships, enhance overall well-being, and create opportunities for broader health interventions.

Accreditation, Credit, and Support

Information on credits offered to SYNC participants for attending institutes, sessions, and plenaries — live or in-person — is available here.

Commercial Support Acknowledgement

This conference is supported, in part, by independent educational grants from ineligible companies. A full list of supporters is available here. All accredited content has been developed and delivered in accordance with the ACCME Standards for Integrity and Independence and the criteria of Joint Accreditation for Interprofessional Continuing Education™, and is free of commercial bias.